Jobs News Biogen To Cut 1,000 Jobs As Focus Turns To Alzheimer S Drug Leqembi Launch
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Jobs News Biogen To Cut 1,000 Jobs As Focus Turns To Alzheimer S Drug Leqembi Launch is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Biogen Cuts Profit Guidance After Deals to Bolster Pipeline
Biogen Inc. cut its full-year profit guidance on higher costs from deals the company has been doing to offset the decline of its aging multiple sclerosis drugs. The Cambridge, Massachusetts-based ... Read More
Biogen's Growth Drivers Hit Third-Quarter Snags; Why This Isn't A 'Fundamental' Problem
Two of Biogen'sBIIB key growth drivers, Leqembi and Skyclarys, hit snags in the third-quarter. But Biogen stock yo-yoed and closed slightly higher. Sales of Friedreich's ataxia treatment, Skyclarys, ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus